Dr. Pattee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2631 S 70th St
Lincoln, NE 68506Phone+1 402-483-7226Fax+1 402-483-5440
Education & Training
University of ColoradoResidency, Neurology, 1987 - 1990
Creighton University School of Medicine (Omaha)Internship, Internal Medicine, 1986 - 1987
McGovern Medical School at UTHealthClass of 1986
Certifications & Licensure
NE State Medical License 1991 - 2026
CO State Medical License 1988 - 2005- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- ALSUntangled #74: Withania Somnifera (Ashwagandha).Sartaj Jhooty, Paul Barkhaus, Andrew Brown, Javier Mascias Cadavid, Gregory T Carter
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01 - ALSUntangled #76: Wahls protocol.Xiaoyan Li, Paul Wicks, Andrew Brown, Akhil Shivaprasad, Maxwell Greene
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-10-09 - Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised,...Leonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, Suma Babu, Michael Benatar
The Lancet. Neurology. 2024-09-01
Journal Articles
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
Mitsubishi Tanabe Pharma America Announces 48-Week Results from Global, Open-Label, Phase 3 Trial of RADICAVA ORS® (Edaravone) in ALSFebruary 27th, 2023- Alliance Backs SLE Research by Minority ScientistsJune 14th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
